(Q38441425)

3 September 2017

title

HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era. (English)

1 reference

3 September 2017

main subject

anti-retroviral agent

0 references

Jane Anderson

14

0 references

Caroline Sabin

object named as

Caroline A Sabin

20

0 references

Deenan Pillay

10

object named as

Deenan Pillay

1 reference

3 September 2017

17

Chloe Orkin

1 reference

3 September 2017

19

Andrew N Phillips

1 reference

3 September 2017

author name string

UK Collaborative HIV Cohort (CHIC) Study Steering Committee

1

1 reference

3 September 2017

Lucy Garvey

2

1 reference

3 September 2017

Alan Winston

3

1 reference

3 September 2017

John Walsh

4

1 reference

3 September 2017

Frank Post

5

1 reference

3 September 2017

Kholoud Porter

6

1 reference

3 September 2017

Brian Gazzard

7

1 reference

3 September 2017

Martin Fisher

8

1 reference

3 September 2017

Clifford Leen

9

1 reference

3 September 2017

Teresa Hill

11

1 reference

3 September 2017

Margaret Johnson

12

1 reference

3 September 2017

Richard Gilson

13

1 reference

3 September 2017

Philippa Easterbrook

15

1 reference

3 September 2017

Loveleen Bansi

16

1 reference

3 September 2017

Jonathan Ainsworth

18

1 reference

3 September 2017

publication date

15 December 2010

1 reference

European Journal of Neurology

3 September 2017

published in

1 reference

3 September 2017

volume

18

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

527-534

1 reference

Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

Changing incidence of central nervous system diseases in the EuroSIDA cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

Late diagnosis of HIV in Europe: definitional and public health challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

Cerebral function tests reveal differences in HIV-infected subjects with and without chronic HCV co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03291.X

10.1111/J.1468-1331.2010.03291.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference